Recruiting studies: Severe Hepatic Impairment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Im
Phase 1 · 22 location(s) · Taiho Oncology, Inc. · NCT04953910 A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
Phase 1 · 4 location(s) · AstraZeneca · NCT07546760 Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment
Phase 1 · 8 location(s) · Novartis Pharmaceuticals · NCT07422610 A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Modera
Phase 1 · 3 location(s) · Eli Lilly and Company · NCT07165002 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · 52 location(s) · AbbVie · NCT06682988 Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants
Phase 1 · 3 location(s) · Institut de Recherches Internationales Servier (I.R.I.S.) · NCT07250633 Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepati
Phase 1 · 2 location(s) · Atea Pharmaceuticals, Inc. · NCT06911320 A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healt
Phase 1 · 3 location(s) · Eli Lilly and Company · NCT07401862 A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib
Phase 1 · 4 location(s) · Genentech, Inc. · NCT07144111 A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT07023354 A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Mode
Phase 1 · 4 location(s) · Incyte Corporation · NCT07559474 Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment
Phase 1 · 3 location(s) · Daiichi Sankyo · NCT06740799 A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function
Phase 1 · 4 location(s) · Pfizer · NCT07231991 Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological
Phase 1 · 4 location(s) · Acrotech Biopharma Inc. · NCT07036133

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.